The effect of atropine, histamine liberators and antihistamines on the absorption of DF32P by mice, rats and guinea pigs.
D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D066298:In Vitro Techniques; D007531:Isoflurophate / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D051379:Mice; D010115:Oxyphenonium / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010759:Phosphorus Isotopes; D051381:Rats; D013347:Subcellular Fractions; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology*
D006634:Histamine H1 Antagonists; D010276:Parasympatholytics; D010759:Phosphorus Isotopes; D007531:Isoflurophate; D003189:p-Methoxy-N-methylphenethylamine; D001285:Atropine; D010115:Oxyphenonium